Anti-interleukin-12 antibody: potential role in preventing relapses of multiple sclerosis.
Publication/Presentation Date
4-1-2000
Abstract
Multiple sclerosis is an inflammatory demyelinating disorder of the central nervous system. Immunological evidence from patients with multiple sclerosis and experimental models suggests that the cytokine interleukin-12 (IL-12) plays an important role in the pathogenesis of inflammatory demyelination. In experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, antibodies that block IL-12 can prevent relapses of the disease. Anti-IL-12 antibodies present a novel approach for preventing relapses in multiple sclerosis.
Volume
13
Issue
4
First Page
233
Last Page
241
ISSN
1173-8804
Published In/Presented At
Fox, R. J., & Rostami, A. M. (2000). Anti-interleukin-12 antibody: potential role in preventing relapses of multiple sclerosis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 13(4), 233–241. https://doi.org/10.2165/00063030-200013040-00002
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
18034530
Department(s)
Administration and Leadership
Document Type
Article